 |
市場調查報告書
商品編碼
1529070
美容醫學市場 - 按類型（手術程序、非手術程序）、產品（基於能源、非基於能源）、性別（男性、女性）、最終用途（醫院、美容中心和醫療水療中心、皮膚科診所） - 全球預測（2024 - 2032）Aesthetic Medicine Market - By Type (Surgical Procedures, Non-surgical Procedures), Product (Energy-based, Non Energy-based), Gender (Male, Female), End-use (Hospitals, Beauty Centres & Medical Spas, Dermatology Clinics) - Global Forecast (2024 - 2032) |
||||||
在治療和設備創新以及簡化核准的推動下，2024 年至 2032 年間，全球美容醫學市場規模將達到 12% 的複合年成長率。微創手術、先進雷射技術和改進的注射劑等進步正在提高治療效果和患者滿意度。此外，加快的監管流程正在促進創新更快進入市場並擴大治療選擇。這些發展滿足了消費者不斷成長的期望，吸引了更多的從業者和投資者，透過為全球美學增強提供更安全、更有效的解決方案來促進市場成長。
例如，2024 年 6 月，著名的開放取用出版商 PeerJ 與美容醫學科學學會 Agora 合作，推出了美容與再生醫學中心。此次合作旨在促進這些領域的創新研究和實際應用。它可以吸引更多的投資，刺激新程序的開發，並加強科學基礎，從而擴大市場的能力並吸引全世界的從業者和患者。
美容醫學行業根據類型、產品、性別、最終用途和地區進行細分。
由於雷射、射頻和超音波等設備的技術創新，到 2032 年，基於能源的細分市場將顯著成長。這些技術為嫩膚、塑身和除毛提供了有效的解決方案，滿足了對非侵入性和微創治療日益成長的需求。皮膚科醫生和整容外科醫生擴大採用這些基於能量的設備，突顯了它們的臨床療效和患者滿意度。隨著不斷的創新提高治療效果，以能量為基礎的細分市場將主導美容醫學市場，解決全球多樣化的美容問題。
由於患者對專業護理和個人化治療的偏好不斷增加，到 2032 年，皮膚科診所領域將取得顯著進展。這些診所提供各種美容手術，如雷射治療、注射和嫩膚治療，滿足不同的美學需求。消費者對皮膚科醫師的專業知識和治療方案的技術進步的信任不斷增強，進一步提升了該細分市場的地位。隨著對美容的需求不斷上升，皮膚科診所將在塑造市場成長軌跡方面發揮關鍵作用。
在可支配收入增加、美容手術意識提高和醫療基礎設施進步的推動下，亞太地區美容醫學行業佔有率從 2024 年到 2032 年將實現大幅複合年成長率。中國、日本和韓國等國家是這一成長的主要貢獻者，這得益於不斷成長的老年人口以及對美麗和健康的文化重視。該地區不斷擴大的醫療旅遊業進一步鞏固了其市場地位。隨著對非侵入性手術的需求上升，亞太地區在美容醫學市場的主導地位將在未來幾年得到鞏固。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 提高對美容程序的認知
- 與醫療美容設備相關的技術進步
- 肥胖盛行率上升
- 越來越多採用非侵入性手術
- 產業陷阱與挑戰
- 與美容手術相關的高成本
- 缺乏報銷和嚴格的監管環境
- 成長動力
- 成長潛力分析
- 技術景觀
- 監管環境
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略展望矩陣
第 5 章：市場估計與預測：按類型，2021 - 2032
- 主要趨勢
- 外科
- 非手術
第 6 章：市場估計與預測：按產品分類，2021 - 2032 年
- 主要趨勢
- 基於能源
- 雷射美容儀
- 基於射頻 (RF) 的美容設備
- 光美容儀
- 超音波美容儀
- 其他能源產品
- 非能源型
- 肉毒桿菌毒素
- 真皮填充劑
- 植入物
- 臉部植入物
- 乳房植入物
- 其他植入物
- 其他非能源產品
第 7 章：市場估計與預測：按性別分類，2021 - 2032 年
- 主要趨勢
- 男性
- 18歲及以下
- 19-34歲
- 35-50歲
- 51-64歲
- 65歲以上
- 女性
- 18歲及以下
- 19-34歲
- 35-50歲
- 51-64歲
- 65歲以上
第 8 章：市場估計與預測：按最終用途，2021 - 2032 年
- 主要趨勢
- 醫院
- 門診手術中心
- 美容中心及醫療水療中心
- 皮膚科診所
- 主頁設定
第 9 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
- 亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 馬來西亞
- 新加坡
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 中東和非洲其他地區
第 10 章：公司簡介
- Apax Partners
- Boston Scientific Corporation
- Bausch Health Companies Inc
- El.En. S.p.A.
- GC Aesthetics plc
- Huadong Medicine Co., Ltd.
- Johnson & Johnson
- Merz Pharma
- Sciton, Inc.
- SharpLight Technologies Inc.
- Sisram Medical Ltd
- Vitruvian Partners LLP
Global Aesthetic Medicine Market size will record a 12% CAGR between 2024 and 2032, driven by innovations in treatments and devices coupled with streamlined approvals. Advances such as minimally invasive procedures, advanced laser technologies, and improved injectables are enhancing treatment efficacy and patient satisfaction. Furthermore, expedited regulatory processes are facilitating quicker market entry for innovations and expanding treatment options. These developments meet rising consumer expectations and attract more practitioners and investors, fostering market growth by offering safer, more effective solutions for aesthetic enhancements globally.
For instance, in June 2024, PeerJ, an acclaimed Open Access publisher, partnered with Agora, the Scientific Society of Aesthetic Medicine, and launched the Aesthetic and Regenerative Medicine Hub. This collaboration aims to foster innovative research and practical applications in these fields. It may attract more investment, spur the development of new procedures, and strengthen scientific foundations, thereby expanding the market's capabilities and appeal to both practitioners and patients worldwide.
The aesthetic medicine industry is segmented based on type, product, gender, end-use, and region.
The energy-based segment will see a notable surge by 2032 due to technological innovations in devices like lasers, radiofrequency, and ultrasound. These technologies offer effective solutions for skin rejuvenation, body contouring, and hair removal, catering to a growing demand for non-invasive and minimally invasive treatments. Increasing adoption of these energy-based devices by dermatologists and cosmetic surgeons underscores their clinical efficacy and patient satisfaction. With ongoing innovations enhancing treatment outcomes, the energy-based segment will dominate the aesthetic medicine market in addressing diverse aesthetic concerns globally.
The dermatology clinics segment will amass remarkable gains by 2032, owing to increasing patient preference for specialized care and personalized treatments. These clinics offer a wide range of cosmetic procedures, such as laser treatments, injectables, and skin rejuvenation therapies, catering to diverse aesthetic needs. Growing consumer trust in dermatologists' expertise and technological advancements in treatment options further boost this segment's prominence. As the demand for aesthetic enhancements continues to rise, dermatology clinics will play a pivotal role in shaping the market's growth trajectory.
Asia Pacific aesthetic medicine industry share will achieve a substantial CAGR from 2024 to 2032, fueled by rising disposable incomes, increasing awareness of aesthetic procedures, and advancing healthcare infrastructure. Countries like China, Japan, and South Korea are key contributors to this growth, supported by a growing elderly population and cultural emphasis on beauty and wellness. The region's expanding medical tourism sector further bolsters its market position. As demand for non-invasive procedures rises, Asia Pacific's prominence in the aesthetic medicine market will solidify in the coming years.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing awareness regarding aesthetic procedures
- 3.2.1.2 Technological advancements associated with medical aesthetic devices
- 3.2.1.3 Rising prevalence of obesity
- 3.2.1.4 Increasing adoption of non-invasive procedures
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost associated with aesthetic procedures
- 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn, Units)
- 5.1 Key trends
- 5.2 Surgical
- 5.3 Non-surgical
Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn, Units)
- 6.1 Key trends
- 6.2 Energy-based
- 6.2.1 Laser-based aesthetic device
- 6.2.2 Radiofrequency (RF)-based aesthetic device
- 6.2.3 Light-based aesthetic device
- 6.2.4 Ultrasound aesthetic device
- 6.2.5 Other energy-based products
- 6.3 Non energy-based
- 6.3.1 Botulinum toxin
- 6.3.2 Dermal fillers
- 6.3.3 Implants
- 6.3.3.1 Facial implants
- 6.3.3.2 Breast implants
- 6.3.3.3 Other implants
- 6.3.4 Others non energy-based products
Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Male
- 7.2.1 18 years and below
- 7.2.2 19-34 years
- 7.2.3 35-50 years
- 7.2.4 51-64 years
- 7.2.5 65 years and above
- 7.3 Female
- 7.3.1 18 years and below
- 7.3.2 19-34 years
- 7.3.3 35-50 years
- 7.3.4 51-64 years
- 7.3.5 65 years and above
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Ambulatory surgical centers
- 8.4 Beauty centers and medical spas
- 8.5 Dermatology clinics
- 8.6 Home settings
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn, Units)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Malaysia
- 9.4.7 Singapore
- 9.4.8 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Apax Partners
- 10.2 Boston Scientific Corporation
- 10.3 Bausch Health Companies Inc
- 10.4 El.En. S.p.A.
- 10.5 GC Aesthetics plc
- 10.6 Huadong Medicine Co., Ltd.
- 10.7 Johnson & Johnson
- 10.8 Merz Pharma
- 10.9 Sciton, Inc.
- 10.10 SharpLight Technologies Inc.
- 10.11 Sisram Medical Ltd
- 10.12 Vitruvian Partners LLP
